Larimar Therapeutics Inc (LRMR) Implied Volatility Current

Tracking LRMR implied volatility helps you identify when options premiums on Larimar Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Larimar Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when LRMR IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Larimar Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For LRMR, tracking metrics like LRMR IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on LRMR signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where LRMR implied volatility sits today versus where it has been. Our scanner ranks Larimar Therapeutics Inc implied volatility against its historical range, surfaces extremes in LRMR IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Larimar Therapeutics Inc IV is rich or cheap — measure it, then act on it.